Fate Therapeutics, Inc. (NASDAQ:FATE) Short Interest Up 7.6% in July

Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) saw a large growth in short interest in July. As of July 31st, there was short interest totalling 27,630,000 shares, a growth of 7.6% from the July 15th total of 25,670,000 shares. Based on an average daily trading volume, of 2,150,000 shares, the days-to-cover ratio is presently […]

Related Keywords

Edwardj Dulac ,Stifel Nicolaus ,Morgan Stanley ,Hightower Advisors ,Financial Services Group Inc ,Raymond James Associates ,Fate Therapeutics Inc ,Cantor Fitzgerald ,Nasdaq ,Advisor Group ,Securities Exchange Commission ,Envestnet Asset Management Inc ,Fate Therapeutics ,Get Free Report ,Exchange Commission ,Asset Management ,Tower Advisors ,Services Group ,Fate Therapeutics Daily ,Nasdaq Fate ,Fate ,Medical ,Stocks ,Options ,Put ,Call ,